Utama › Kanser Pankreas › Colorado › Denver
Kajian klinikal Kanser Pankreas di Denver, CO
13 kajian untuk Kanser Pankreas sedang mencari peserta di lokasi dalam dan sekitar Denver (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
The Vanguard Study: Testing a New Way to Screen for Cancer
Mengambil pesertaSukarelawan sihat dialu-alukan
- Kaiser Permanente-Franklin, Denver
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Mengambil pesertaFasa 1
- Sarah Cannon Research Institute at HealthOne, Denver
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Mengambil pesertaFasa 3
- Investigative Site US071, Denver
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Mengambil pesertaKajian pemerhatian
- University of Colorado, Denver
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Mengambil pesertaFasa 1
- Sarah Cannon Research Institute - Denver DDU, Denver
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Mengambil pesertaFasa 3
- AdventHealth Porter, Denver
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Sarah Cannon Research Institute, Denver
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Mengambil pesertaFasa 1
- Sarah Cannon, SCRI Oncology Partners - Health One, Denver
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
- Sarah Cannon Research Institute, Denver
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Mengambil pesertaFasa 2
- Ohio State University Telemedicine, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Denver
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
Mengambil pesertaKajian pemerhatian
- University of Colorado, Denver
Kajian Kanser Pankreas di bandar lain
- Houston, TX61 kajian
- New York City, NY60 kajian
- Boston, MA43 kajian
- Nashville, TN39 kajian
- Los Angeles, CA35 kajian
- St. Louis, MO33 kajian
- Arlington, VA33 kajian
- Baltimore, MD31 kajian
- San Antonio, TX31 kajian
- Philadelphia, PA26 kajian
- Tampa, FL26 kajian
- Durham, NC24 kajian
Kajian lain di Denver
- Kanser Metastatik29 kajian
- Kanser Payudara29 kajian
- Kanser Paru-paru Bukan Sel Kecil27 kajian
- Mieloma Pelbagai27 kajian
- Kanser Kolorektal23 kajian
- Melanoma19 kajian
- Kanser Prostat19 kajian
- Kanser (semua jenis)18 kajian
- Kanser Ovari16 kajian
- Kanser Paru-paru16 kajian
- Kanser Endometrium15 kajian
- Limfoma Bukan Hodgkin14 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.